Published in Clin Nutr on April 01, 2000
Ischaemic heart disease--a new issue in cystic fibrosis? J R Soc Med (2010) 0.75
IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses. Immunity (1996) 6.16
Targeted disruption of the MHC class II Aa gene in C57BL/6 mice. Int Immunol (1993) 3.73
Multiple mutations in highly conserved residues are found in mildly affected cystic fibrosis patients. Cell (1990) 3.29
Early discharge for patients with exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial. Thorax (2000) 2.59
Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice. J Cyst Fibros (2008) 2.56
Polymorphic admixture typing in human ethnic populations. Am J Hum Genet (1994) 2.37
Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: a consensus conference report. Diabetes Res Clin Pract (1999) 2.32
Single-centre cross-sectional analysis of advance care planning among elderly inpatients. Intern Med J (2014) 2.18
Congenital bilateral absence of the vas deferens. A primarily genital form of cystic fibrosis. JAMA (1992) 2.11
Activation of MHC class I, II, and CD40 gene expression by histone deacetylase inhibitors. J Immunol (2000) 2.07
Hippocampal representation in place learning. J Neurosci (1990) 2.05
Structure and function of enzymes involved in the biosynthesis of phenylpropanoids. Plant Physiol Biochem (2007) 2.01
Evening primrose oil in atopic eczema. Lancet (1990) 2.01
Two steps forward, one step back: advance care planning, Australian regulatory frameworks and the Australian Medical Association. Intern Med J (2007) 1.99
Structure of the rat osteocalcin gene and regulation of vitamin D-dependent expression. Proc Natl Acad Sci U S A (1989) 1.98
Platelet size in stroke patients. Stroke (1995) 1.84
Microvillus inclusion disease: an inherited defect of brush-border assembly and differentiation. N Engl J Med (1989) 1.77
Correlation of sweat chloride concentration with classes of the cystic fibrosis transmembrane conductance regulator gene mutations. J Pediatr (1995) 1.70
Infection with Burkholderia cepacia in cystic fibrosis: outcome following lung transplantation. Am J Respir Crit Care Med (2001) 1.69
Interobserver agreement among sleep scorers from different centers in a large dataset. Sleep (2000) 1.63
Nuclear transplantation. An udder way of making lambs. Nature (1997) 1.62
ASPIRE registry: assessing the Spectrum of Pulmonary hypertension Identified at a REferral centre. Eur Respir J (2011) 1.61
Energy expenditure and body composition in children with spastic quadriplegic cerebral palsy. J Pediatr (1996) 1.56
Recommendations for the classification of diseases as CFTR-related disorders. J Cyst Fibros (2011) 1.54
The challenge of patients' unmet palliative care needs in the final stages of chronic illness. Palliat Med (2007) 1.54
Health care utilization as a marker for suicidal behavior on an American Indian Reservation. J Gen Intern Med (1996) 1.54
The use of dexamethasone in women with preterm premature rupture of membranes--a multicentre, double-blind, placebo-controlled, randomised trial. Dexiprom Study Group. S Afr Med J (1999) 1.53
Randomised controlled trial comparing effectiveness of touch screen system with leaflet for providing women with information on prenatal tests. BMJ (2000) 1.52
High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis. N Engl J Med (1997) 1.51
Energy expenditure of patients with cystic fibrosis. J Pediatr (1987) 1.51
Effect of cimetidine and sodium bicarbonate on pancreatic replacement therapy in cystic fibrosis. Gut (1980) 1.50
Acute pancreatitis in childhood. J Pediatr (1988) 1.49
Effect of low- and high-fat, peptide-based diets on body composition and disease activity in adolescents with active Crohn's disease. JPEN J Parenter Enteral Nutr (1997) 1.48
Use of bioelectrical impedance analysis to measure total body water in patients with cystic fibrosis. J Pediatr Gastroenterol Nutr (1993) 1.47
Shwachman syndrome: phenotypic manifestations of sibling sets and isolated cases in a large patient cohort are similar. J Pediatr (1999) 1.47
Mutation analysis of the MEN1 gene in multiple endocrine neoplasia type 1, familial acromegaly and familial isolated hyperparathyroidism. J Clin Endocrinol Metab (1998) 1.46
Molecular consequences of cystic fibrosis transmembrane regulator (CFTR) gene mutations in the exocrine pancreas. Gut (2003) 1.45
A position paper of the North American Society for Pediatric Gastroenterology and Nutrition. Pediatric gastroenterology Workforce Survey and future supply and demand. J Pediatr Gastroenterol Nutr (1998) 1.45
Bile acid secretion in cystic fibrosis: evidence for a defect unrelated to fat malabsorption. Gut (1986) 1.44
Preliminary studies of mineralization during distraction osteogenesis. Clin Orthop Relat Res (1990) 1.44
The assessment and management of strabismus and amblyopia: a national audit. Eye (Lond) (2002) 1.43
Validation study of a computerized version of the Western Ontario and McMaster Universities VA3.0 Osteoarthritis Index. J Rheumatol (1997) 1.42
Improvement in out-of-hours outcomes following the implementation of Hospital at Night. QJM (2009) 1.41
Induction of cellular thymidine kinase occurs at the mRNA level. Mol Cell Biol (1985) 1.40
A laser speckle imaging technique for measuring tissue perfusion. IEEE Trans Biomed Eng (2004) 1.39
Local advancement flap for coverage of vascular anastomoses. Am J Surg (1998) 1.38
Determining the validity of advance directives. Med J Aust (2000) 1.38
Development and clinical validation of a molecular diagnostic assay to detect CTX-M-type beta-lactamases in Enterobacteriaceae. Clin Microbiol Infect (2007) 1.36
Alternate cardiovascular baseline assessment techniques: vanilla or resting baseline. Psychophysiology (1992) 1.35
A rational approach to the nutritional care of patients with cystic fibrosis. J R Soc Med (1989) 1.35
Age-related alterations of immunoreactive pancreatic cationic trypsinogen in sera from cystic fibrosis patients with and without pancreatic insufficiency. Pediatr Res (1986) 1.34
Preclinical trials in autosomal dominant AD: implementation of the DIAN-TU trial. Rev Neurol (Paris) (2013) 1.33
Effects of long-term nutritional rehabilitation on body composition and clinical status in malnourished children and adolescents with cystic fibrosis. J Pediatr (1985) 1.30
Cystic fibrosis transmembrane conductance regulator and obstructive azoospermia. Lancet (1995) 1.29
Recommendations for management of liver and biliary tract disease in cystic fibrosis. Cystic Fibrosis Foundation Hepatobiliary Disease Consensus Group. J Pediatr Gastroenterol Nutr (1999) 1.28
Treatment of distal intestinal obstruction syndrome in cystic fibrosis with a balanced intestinal lavage solution. Lancet (1986) 1.28
Pathology of pancreatic and intestinal disorders in cystic fibrosis. J R Soc Med (1998) 1.28
Skeletal phenotype in patients with Shwachman-Diamond syndrome and mutations in SBDS. Clin Genet (2004) 1.27
Gene transfer into murine stem cells and mice using retroviral vectors. Cold Spring Harb Symp Quant Biol (1985) 1.27
Evidence for a primary defect of pancreatic HCO3-secretion in cystic fibrosis. Pediatr Res (1982) 1.26
Uncertainty in the diagnosis of cystic fibrosis: possible role of in vivo nasal potential difference measurements. J Pediatr (1998) 1.26
Shwachman syndrome: exocrine pancreatic dysfunction and variable phenotypic expression. Gastroenterology (1996) 1.25
Urinary tract infection prophylaxis using Escherichia coli 83972 in spinal cord injured patients. J Urol (2000) 1.24
IL-12-deficient mice are defective but not devoid of type 1 cytokine responses. Ann N Y Acad Sci (1996) 1.24
Dietary cysteine reduces the methionine requirement in men. Am J Clin Nutr (2001) 1.23
Shwachman-Diamond syndrome with exocrine pancreatic dysfunction and bone marrow failure maps to the centromeric region of chromosome 7. Am J Hum Genet (2001) 1.21
Virulence properties of Escherichia coli 83972, a prototype strain associated with asymptomatic bacteriuria. Infect Immun (1999) 1.20
Immunolocalisation of Burkholderia cepacia in the lungs of cystic fibrosis patients. J Med Microbiol (2001) 1.19
The distribution of immunoreactive interferon-alpha in normal human tissues. Immunology (1989) 1.18
Colipase and lipase secretion in childhood-onset pancreatic insufficiency. Delineation of patients with steatorrhea secondary to relative colipase deficiency. Gastroenterology (1984) 1.17
Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy. Consensus Committee. J Pediatr (1995) 1.16
Immunological significance of Mycobacterium leprae cell walls. Proc Natl Acad Sci U S A (1988) 1.15
Comparison of laser speckle and laser Doppler perfusion imaging: measurement in human skin and rabbit articular tissue. Med Biol Eng Comput (2002) 1.15
Total human body protein synthesis in relation to protein requirements at various ages. Nature (1975) 1.13
Murine gamma interferon activates the release of a macrophage-derived Ia-inducing factor that transfers Ia inductive capacity. J Exp Med (1984) 1.13
Dietary intakes of young children with cystic fibrosis: is there a difference? J Pediatr Gastroenterol Nutr (1996) 1.12
Phase I study of topotecan for pediatric patients with malignant solid tumors. J Clin Oncol (1994) 1.12
Rituximab in combination with fludarabine chemotherapy in low-grade or follicular lymphoma. J Clin Oncol (2005) 1.11
Proximal and distal regulatory elements that influence in vivo expression of a cell cycle-dependent human H4 histone gene. Proc Natl Acad Sci U S A (1987) 1.11
Predictors of pulmonary exacerbations in patients with cystic fibrosis infected with multi-resistant bacteria. Thorax (2006) 1.11
Late gastrointestinal bleeding and protein loss after distal small-bowel resection in infancy. J Pediatr Gastroenterol Nutr (1989) 1.11
Total sulfur amino acid requirement in young men as determined by indicator amino acid oxidation with L-[1-13C]phenylalanine. Am J Clin Nutr (2001) 1.10
Improved primer design for multiplex PCR analysis of vancomycin-resistant Enterococcus spp. J Clin Microbiol (2001) 1.10
Typing of HLA-DQA1 and DQB1 using DNA single-strand conformation polymorphism. Hum Immunol (1992) 1.09
Measuring resting energy expenditure in clinical practice. J Pediatr (1995) 1.07
Spatial correlation between thyroid epithelial cells expressing class II MHC molecules and interferon-gamma-containing lymphocytes in human thyroid autoimmune disease. Clin Exp Immunol (1991) 1.06
Spectral and other physicochemical properties of submicron powders of hematite (alpha-Fe2O3), maghemite (gamma-Fe2O3), magnetite (Fe3O4), goethite (alpha-FeOOH), and lepidocrocite (gamma-FeOOH). J Geophys Res (1985) 1.05
Localization of the gene for the nevoid basal cell carcinoma syndrome. Am J Hum Genet (1994) 1.03
Malnutrition: a cause of elevated sweat chloride concentration. Acta Paediatr Scand (1986) 1.03
Meconium ileus in the absence of cystic fibrosis. Arch Dis Child (1992) 1.03
Lavage treatment of distal intestinal obstruction syndrome in children with cystic fibrosis. Pediatrics (1989) 1.02
The molecular basis of disease variability among cystic fibrosis patients carrying the 3849+10 kb C-->T mutation. Genomics (1998) 1.02
The association of cystic fibrosis, gastroesophageal reflux, and reduced pulmonary function. Can Assoc Radiol J (1988) 1.00
Identification of an enhancer-like element upstream from a cell cycle dependent human H4 histone gene. J Cell Physiol (1987) 0.99
Laryngeal dystonia (spasmodic dysphonia): observations of 901 patients and treatment with botulinum toxin. Adv Neurol (1998) 0.99
Aggregation between teratocarcinoma cells and preimplantation mouse embryos. J Embryol Exp Morphol (1980) 0.99